Medifast MED
NYSE MED
$12.10 +0.04 (+0.33%)
As of: Oct 21, 2026 · 3:59 PM EDT

Medifast (MED) Current Deferred Revenue (2018 - 2020)

Updated

Medifast (MED) recorded Current Deferred Revenue of $7.61 million in Q4 2020, up 75.5% from $4.33 million a year earlier.

Analysis

Medifast (MED) Current Deferred Revenue (2018 - 2020) Analysis & Trends

  • Across earlier years, Current Deferred Revenue came in at $4.33 million in FY2019 (+54.9%) and $2.8 million in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Procter & Gamble 367.14 Bn 322.89 Bn 10.28 Bn
2 Colgate Palmolive 74.80 Bn 69.53 Bn 3.30 Bn
3 Estee Lauder Companies 37.60 Bn 25.67 Bn 2.74 Bn
4 Kenvue 36.63 Bn 32.25 Bn 2.30 Bn
5 Kimberly Clark 35.53 Bn 32.72 Bn 1.60 Bn
6 Church & Dwight 24.88 Bn 23.41 Bn 693.90 Mn
7 Clorox 10.33 Bn 8.61 Bn 804.00 Mn
8 e.l.f. Beauty 6.73 Bn 5.71 Bn 398.84 Mn
9 Reynolds Consumer Products 4.77 Bn 4.44 Bn 245.00 Mn
10 Medifast 134.62 Mn -544.93 Mn 53.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 7.61 Mn
Dec 31, 2019 4.33 Mn
Dec 31, 2018 2.80 Mn
API Access

Medifast Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=MED&period=max&api_key=YOUR_API_KEY